Literature DB >> 19833723

HIV-1 transmission by dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) is regulated by determinants in the carbohydrate recognition domain that are absent in liver/lymph node-SIGN (L-SIGN).

Nancy P Y Chung1, Sabine K J Breun, Arman Bashirova, Joerg G Baumann, Thomas D Martin, Jaideep M Karamchandani, Jason W Rausch, Stuart F J Le Grice, Li Wu, Mary Carrington, Vineet N Kewalramani.   

Abstract

In this study, we identify determinants in dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) necessary for human immunodeficiency virus, type 1 (HIV-1), transmission. Although human B cell lines expressing DC-SIGN efficiently capture and transmit HIV-1 to susceptible target cells, cells expressing the related molecule liver/lymph node-specific ICAM-3-grabbing nonintegrin (L-SIGN) do not. To understand the differences between DC-SIGN and L-SIGN that affect HIV-1 interactions, we developed Raji B cell lines expressing different DC-SIGN/L-SIGN chimeras. Testing of the chimeras demonstrated that replacement of the DC-SIGN carbohydrate-recognition domain (CRD) with that of L-SIGN was sufficient to impair virus binding and prevent transmission. Conversely, the ability to bind and transmit HIV-1 was conferred to L-SIGN chimeras containing the DC-SIGN CRD. We identified Trp-258 in the DC-SIGN CRD to be essential for HIV-1 transmission. Although introduction of a K270W mutation at the same position in L-SIGN was insufficient for HIV-1 binding, an L-SIGN mutant molecule with K270W and a C-terminal DC-SIGN CRD subdomain transmitted HIV-1. These data suggest that DC-SIGN structural elements distinct from the oligosaccharide-binding site are required for HIV-1 glycoprotein selectivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19833723      PMCID: PMC2804366          DOI: 10.1074/jbc.M109.030619

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  C-type lectin receptors on dendritic cells and Langerhans cells.

Authors:  Carl G Figdor; Yvette van Kooyk; Gosse J Adema
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

2.  Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection.

Authors:  Franck Halary; Ali Amara; Hugues Lortat-Jacob; Martin Messerle; Thierry Delaunay; Corinne Houlès; Franck Fieschi; Fernando Arenzana-Seisdedos; Jean François Moreau; Julie Déchanet-Merville
Journal:  Immunity       Date:  2002-11       Impact factor: 31.745

3.  C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans.

Authors:  Carmen P Alvarez; Fátima Lasala; Jaime Carrillo; Oscar Muñiz; Angel L Corbí; Rafael Delgado
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding.

Authors:  Patrick W-P Hong; Karen B Flummerfelt; Aymeric de Parseval; Kevin Gurney; John H Elder; Benhur Lee
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro.

Authors:  Elizabeth J Soilleux; Lesley S Morris; George Leslie; Jihed Chehimi; Qi Luo; Ernest Levroney; John Trowsdale; Luis J Montaner; Robert W Doms; Drew Weissman; Nicholas Coleman; Benhur Lee
Journal:  J Leukoc Biol       Date:  2002-03       Impact factor: 4.962

6.  Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission.

Authors:  Li Wu; Thomas D Martin; Rosemay Vazeux; Derya Unutmaz; Vineet N KewalRamani
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  Cell type-dependent retention and transmission of HIV-1 by DC-SIGN.

Authors:  Christine Trumpfheller; Chae Gyu Park; Jennifer Finke; Ralph M Steinman; Angela Granelli-Piperno
Journal:  Int Immunol       Date:  2003-02       Impact factor: 4.823

8.  Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells.

Authors:  Rogier W Sanders; Esther C de Jong; Christopher E Baldwin; Joost H N Schuitemaker; Martien L Kapsenberg; Ben Berkhout
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Diversity of receptors binding HIV on dendritic cell subsets.

Authors:  Stuart G Turville; Paul U Cameron; Amanda Handley; George Lin; Stefan Pöhlmann; Robert W Doms; Anthony L Cunningham
Journal:  Nat Immunol       Date:  2002-09-23       Impact factor: 25.606

10.  Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR.

Authors:  George Lin; Graham Simmons; Stefan Pöhlmann; Frédéric Baribaud; Houping Ni; George J Leslie; Beth S Haggarty; Paul Bates; Drew Weissman; James A Hoxie; Robert W Doms
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  9 in total

1.  HIV-1 envelope proteins up-regulate N 6-methyladenosine levels of cellular RNA independently of viral replication.

Authors:  Nagaraja Tirumuru; Li Wu
Journal:  J Biol Chem       Date:  2019-01-07       Impact factor: 5.157

2.  Human Blood-Circulating Basophils Capture HIV-1 and Mediate Viral trans-Infection of CD4+ T Cells.

Authors:  Ai-Ping Jiang; Jin-Feng Jiang; Ming-Gao Guo; Yong-Mei Jin; Yu-Ye Li; Jian-Hua Wang
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

3.  Multivalent Cluster Nanomolecules for Inhibiting Protein-Protein Interactions.

Authors:  Elaine A Qian; Yanxiao Han; Marco S Messina; Heather D Maynard; Petr Král; Alexander M Spokoyny
Journal:  Bioconjug Chem       Date:  2019-09-23       Impact factor: 4.774

4.  HIV-1 expressing the envelopes of transmitted/founder or control/reference viruses have similar infection patterns of CD4 T-cells in human cervical tissue ex vivo.

Authors:  Melanie Merbah; Anush Arakelyan; Tara Edmonds; Christina Ochsenbauer; John C Kappes; Robin J Shattock; Jean-Charles Grivel; Leonid B Margolis
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

5.  Penicillium marneffei-stimulated dendritic cells enhance HIV-1 trans-infection and promote viral infection by activating primary CD4+ T cells.

Authors:  Yan Qin; Yuye Li; Wan Liu; Renrong Tian; Qianqian Guo; Shaoyou Li; Hongbin Li; Daojun Zhang; Yongtang Zheng; Li Wu; Ke Lan; Jianhua Wang
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

6.  Oligomerization domains in the glycan-binding receptors DC-SIGN and DC-SIGNR: Sequence variation and stability differences.

Authors:  Ália Dos Santos; Andreas Hadjivasiliou; Felipe Ossa; Novandy K Lim; Aylin Turgut; Maureen E Taylor; Kurt Drickamer
Journal:  Protein Sci       Date:  2016-12-22       Impact factor: 6.725

7.  Dissecting Multivalent Lectin-Carbohydrate Recognition Using Polyvalent Multifunctional Glycan-Quantum Dots.

Authors:  Yuan Guo; Inga Nehlmeier; Emma Poole; Chadamas Sakonsinsiri; Nicole Hondow; Andy Brown; Qing Li; Shuang Li; Jessie Whitworth; Zhongjun Li; Anchi Yu; Rik Brydson; W Bruce Turnbull; Stefan Pöhlmann; Dejian Zhou
Journal:  J Am Chem Soc       Date:  2017-08-17       Impact factor: 15.419

8.  Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Multivalent Protein-Ligand Interactions.

Authors:  Yuan Guo; Chadamas Sakonsinsiri; Inga Nehlmeier; Martin A Fascione; Haiyan Zhang; Weili Wang; Stefan Pöhlmann; W Bruce Turnbull; Dejian Zhou
Journal:  Angew Chem Int Ed Engl       Date:  2016-03-16       Impact factor: 15.336

9.  Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Multivalent Protein-Ligand Interactions.

Authors:  Yuan Guo; Chadamas Sakonsinsiri; Inga Nehlmeier; Martin A Fascione; Haiyan Zhang; Weili Wang; Stefan Pöhlmann; W Bruce Turnbull; Dejian Zhou
Journal:  Angew Chem Weinheim Bergstr Ger       Date:  2016-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.